{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:07:51Z","timestamp":1772136471409,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"China Scholarship Council Grant","award":["202008230186 to L.S."],"award-info":[{"award-number":["202008230186 to L.S."]}]},{"DOI":"10.13039\/501100002996","name":"Dutch Heart Foundation","doi-asserted-by":"crossref","award":["2018-30 (CVON-PREDICT2)"],"award-info":[{"award-number":["2018-30 (CVON-PREDICT2)"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CarMa","award":["01-003-2022-0358"],"award-info":[{"award-number":["01-003-2022-0358"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-19321-y","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:48:45Z","timestamp":1760017725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiac remodeling pathways do not accelerate disease onset and severity in a mouse model of PLN-R14del cardiomyopathy"],"prefix":"10.1038","volume":"15","author":[{"given":"Liu","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth M.","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla Arevalo","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian Oliveira Nunes","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman H. W.","family":"Sillj\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"19321_CR1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.bpj.2019.01.013","volume":"116","author":"JP Glaves","year":"2019","unstructured":"Glaves, J. P., Primeau, J. O., Espinoza-Fonseca, L. M., Lemieux, M. J. & Young, H. S. The phospholamban pentamer alters function of the sarcoplasmic reticulum calcium pump SERCA. Biophys. J. 116, 633\u2013647. https:\/\/doi.org\/10.1016\/j.bpj.2019.01.013 (2019).","journal-title":"Biophys. J."},{"key":"19321_CR2","doi-asserted-by":"publisher","first-page":"1162205","DOI":"10.3389\/fcvm.2023.1162205","volume":"10","author":"E Vafiadaki","year":"2023","unstructured":"Vafiadaki, E., Glijnis, P. C., Doevendans, P. A., Kranias, E. G. & Sanoudou, D. Phospholamban R14del disease: the past, the present and the future. Front. Cardiovasc. Med. 10, 1162205. https:\/\/doi.org\/10.3389\/fcvm.2023.1162205 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"19321_CR3","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1073\/pnas.0510519103","volume":"103","author":"K Haghighi","year":"2006","unstructured":"Haghighi, K. et al. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc. Natl. Acad. Sci. U S A. 103, 1388\u20131393. https:\/\/doi.org\/10.1073\/pnas.0510519103 (2006).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"19321_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s12471-013-0401-3","volume":"21","author":"PA van der Zwaag","year":"2013","unstructured":"van der Zwaag, P. A. et al. Recurrent and founder mutations in the Netherlands-Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy. Neth. Heart J. 21, 286\u2013293. https:\/\/doi.org\/10.1007\/s12471-013-0401-3 (2013).","journal-title":"Neth. Heart J."},{"key":"19321_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2024.02.017","author":"NM Stege","year":"2024","unstructured":"Stege, N. M., de Boer, R. A., Makarewich, C. A., van der Meer, P. & Sillj\u00e9, H. H. W. Reassessing the mechanisms of PLN-R14del cardiomyopathy. JACC: Basic. Translational Sci. https:\/\/doi.org\/10.1016\/j.jacbts.2024.02.017 (2024).","journal-title":"JACC: Basic. Translational Sci."},{"key":"19321_CR6","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1161\/CIRCRESAHA.123.323304","volume":"133","author":"NM Stege","year":"2023","unstructured":"Stege, N. M. et al. DWORF extends life span in a PLN-R14del cardiomyopathy mouse model by reducing abnormal sarcoplasmic reticulum clusters. Circ. Res. 133, 1006\u20131021. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.323304 (2023).","journal-title":"Circ. Res."},{"key":"19321_CR7","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/his.12963","volume":"69","author":"WP Te Rijdt","year":"2016","unstructured":"Te Rijdt, W. P. et al. Phospholamban p.Arg14del cardiomyopathy is characterized by phospholamban aggregates, aggresomes, and autophagic degradation. Histopathology 69, 542\u2013550. https:\/\/doi.org\/10.1111\/his.12963 (2016).","journal-title":"Histopathology"},{"key":"19321_CR8","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","volume":"14","author":"PA van der Zwaag","year":"2012","unstructured":"van der Zwaag, P. A. et al. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur. J. Heart Fail. 14, 1199\u20131207. https:\/\/doi.org\/10.1093\/eurjhf\/hfs119 (2012).","journal-title":"Eur. J. Heart Fail."},{"key":"19321_CR9","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.hrthm.2009.01.016","volume":"6","author":"MG Posch","year":"2009","unstructured":"Posch, M. G. et al. Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes. Heart Rhythm. 6, 480\u2013486. https:\/\/doi.org\/10.1016\/j.hrthm.2009.01.016 (2009).","journal-title":"Heart Rhythm"},{"key":"19321_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s12471-023-01800-4","volume":"31","author":"FHM van Lint","year":"2023","unstructured":"van Lint, F. H. M. et al. Exercise does not influence development of phenotype in PLN p.(Arg14del) cardiomyopathy. Neth. Heart J. 31, 291\u2013299. https:\/\/doi.org\/10.1007\/s12471-023-01800-4 (2023).","journal-title":"Neth. Heart J."},{"key":"19321_CR11","doi-asserted-by":"publisher","unstructured":"van der Voorn, S. M. et al. Lack of evidence for the role of the p.(Ser96Ala) polymorphism in histidine-rich calcium binding protein as a secondary hit in cardiomyopathies. Int. J. Mol. Sci. 24.  https:\/\/doi.org\/10.3390\/ijms242115931 (2023).","DOI":"10.3390\/ijms242115931"},{"key":"19321_CR12","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s12265-022-10347-5","volume":"16","author":"EA Lopera-Maya","year":"2023","unstructured":"Lopera-Maya, E. A. et al. Phenotypic and genetic factors associated with absence of cardiomyopathy symptoms in PLN:c.40_42delAGA carriers. J. Cardiovasc. Transl. Res. 16, 1251\u20131266. https:\/\/doi.org\/10.1007\/s12265-022-10347-5 (2023).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"19321_CR13","doi-asserted-by":"publisher","first-page":"9819","DOI":"10.1038\/s41598-020-66656-9","volume":"10","author":"TR Eijgenraam","year":"2020","unstructured":"Eijgenraam, T. R. et al. The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapy. Sci. Rep. 10, 9819. https:\/\/doi.org\/10.1038\/s41598-020-66656-9 (2020).","journal-title":"Sci. Rep."},{"key":"19321_CR14","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1093\/cvr\/cvad037","volume":"119","author":"F Funk","year":"2023","unstructured":"Funk, F. et al. Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation. Cardiovasc. Res. 119, 1568\u20131582. https:\/\/doi.org\/10.1093\/cvr\/cvad037 (2023).","journal-title":"Cardiovasc. Res."},{"key":"19321_CR15","doi-asserted-by":"publisher","first-page":"108118","DOI":"10.1016\/j.jbc.2024.108118","volume":"301","author":"SR Cleary","year":"2025","unstructured":"Cleary, S. R. et al. Dilated cardiomyopathy variant R14del increases phospholamban pentamer stability, blunting dynamic regulation of calcium. J. Biol. Chem. 301, 108118. https:\/\/doi.org\/10.1016\/j.jbc.2024.108118 (2025).","journal-title":"J. Biol. Chem."},{"key":"19321_CR16","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1161\/CIRCULATIONAHA.111.044354","volume":"125","author":"P Gurha","year":"2012","unstructured":"Gurha, P. et al. Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction. Circulation 125, 2751\u20132761. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.044354 (2012).","journal-title":"Circulation"},{"key":"19321_CR17","doi-asserted-by":"publisher","first-page":"5067544","DOI":"10.1155\/2022\/5067544","volume":"2022","author":"C Hu","year":"2022","unstructured":"Hu, C. et al. Peroxiredoxin-5 knockdown accelerates pressure overload-Induced cardiac hypertrophy in mice. Oxid. Med. Cell. Longev. 2022, 5067544. https:\/\/doi.org\/10.1155\/2022\/5067544 (2022).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"19321_CR18","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.115.020502","volume":"133","author":"A Shirakabe","year":"2016","unstructured":"Shirakabe, A. et al. Drp1-dependent mitochondrial autophagy plays a protective role against pressure Overload-Induced mitochondrial dysfunction and heart failure. Circulation 133, 1249\u20131263. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.020502 (2016).","journal-title":"Circulation"},{"key":"19321_CR19","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1093\/cvr\/cvy141","volume":"114","author":"AO Melleby","year":"2018","unstructured":"Melleby, A. O. et al. A novel method for high precision aortic constriction that allows for generation of specific cardiac phenotypes in mice. Cardiovasc. Res. 114, 1680\u20131690. https:\/\/doi.org\/10.1093\/cvr\/cvy141 (2018).","journal-title":"Cardiovasc. Res."},{"key":"19321_CR20","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 18, e3000410. https:\/\/doi.org\/10.1371\/journal.pbio.3000410 (2020).","journal-title":"PLoS Biol."},{"key":"19321_CR21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/CIRCGENETICS.113.000374","volume":"7","author":"IA van Rijsingen","year":"2014","unstructured":"van Rijsingen, I. A. et al. Outcome in phospholamban R14del carriers: results of a large multicentre cohort study. Circ. Cardiovasc. Genet. 7, 455\u2013465. https:\/\/doi.org\/10.1161\/CIRCGENETICS.113.000374 (2014).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"19321_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.hrthm.2021.11.009","volume":"19","author":"R de Brouwer","year":"2022","unstructured":"de Brouwer, R. et al. Sex-specific aspects of phospholamban cardiomyopathy: the importance and prognostic value of low-voltage electrocardiograms. Heart Rhythm. 19, 427\u2013434. https:\/\/doi.org\/10.1016\/j.hrthm.2021.11.009 (2022).","journal-title":"Heart Rhythm"},{"key":"19321_CR23","doi-asserted-by":"publisher","unstructured":"Eijgenraam, T. R. et al. Antisense therapy attenuates phospholamban p.(Arg14del) cardiomyopathy in mice and reverses protein aggregation. Int. J. Mol. Sci. 23. https:\/\/doi.org\/10.3390\/ijms23052427 (2022).","DOI":"10.3390\/ijms23052427"},{"key":"19321_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/s0022-4804(03)00114-8","volume":"112","author":"BS Knipp","year":"2003","unstructured":"Knipp, B. S. et al. Ultrasound measurement of aortic diameters in rodent models of aneurysm disease. J. Surg. Res. 112, 97\u2013101. https:\/\/doi.org\/10.1016\/s0022-4804(03)00114-8 (2003).","journal-title":"J. Surg. Res."},{"key":"19321_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/cvr\/cvaa110","volume":"117","author":"S Zacchigna","year":"2021","unstructured":"Zacchigna, S. et al. Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC working group on myocardial function. Cardiovasc. Res. 117, 43\u201359. https:\/\/doi.org\/10.1093\/cvr\/cvaa110 (2021).","journal-title":"Cardiovasc. Res."},{"key":"19321_CR26","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1161\/CIRCRESAHA.111.259754","volume":"110","author":"EG Kranias","year":"2012","unstructured":"Kranias, E. G. & Hajjar, R. J. Modulation of cardiac contractility by the phospholamban\/SERCA2a regulatome. Circ. Res. 110, 1646\u20131660. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.259754 (2012).","journal-title":"Circ. Res."},{"key":"19321_CR27","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s00018-024-05471-1","volume":"81","author":"E Vafiadaki","year":"2024","unstructured":"Vafiadaki, E., Kranias, E. G., Eliopoulos, A. G. & Sanoudou, D. The phospholamban R14del generates pathogenic aggregates by impairing autophagosome-lysosome fusion. Cell. Mol. Life Sci. 81, 450. https:\/\/doi.org\/10.1007\/s00018-024-05471-1 (2024).","journal-title":"Cell. Mol. Life Sci."},{"key":"19321_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1749-6632.2009.05100.x","volume":"1188","author":"H Taegtmeyer","year":"2010","unstructured":"Taegtmeyer, H., Sen, S. & Vela, D. Return to the fetal gene program: a suggested metabolic link to gene expression in the heart. Ann. N Y Acad. Sci. 1188, 191\u2013198. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05100.x (2010).","journal-title":"Ann. N Y Acad. Sci."},{"key":"19321_CR29","doi-asserted-by":"publisher","first-page":"C166","DOI":"10.1152\/ajpcell.00021.2020","volume":"319","author":"E Tracy","year":"2020","unstructured":"Tracy, E., Rowe, G. & LeBlanc, A. J. Cardiac tissue remodeling in healthy aging: the road to pathology. Am. J. Physiol. Cell. Physiol. 319, C166\u2013C182. https:\/\/doi.org\/10.1152\/ajpcell.00021.2020 (2020).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"19321_CR30","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1161\/01.CIR.0000137836.95625.D4","volume":"110","author":"K Okada","year":"2004","unstructured":"Okada, K. et al. Prolonged Endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of Endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation 110, 705\u2013712. https:\/\/doi.org\/10.1161\/01.CIR.0000137836.95625.D4 (2004).","journal-title":"Circulation"},{"key":"19321_CR31","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.bbrc.2012.04.048","volume":"421","author":"CS Park","year":"2012","unstructured":"Park, C. S., Cha, H., Kwon, E. J., Sreenivasaiah, P. K. & Kim, D. H. The chemical chaperone 4-phenylbutyric acid attenuates pressure-overload cardiac hypertrophy by alleviating endoplasmic reticulum stress. Biochem. Biophys. Res. Commun. 421, 578\u2013584. https:\/\/doi.org\/10.1016\/j.bbrc.2012.04.048 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"19321_CR32","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1161\/CIRCULATIONAHA.120.049844","volume":"144","author":"DAM Feyen","year":"2021","unstructured":"Feyen, D. A. M. et al. Unfolded protein response as a compensatory mechanism and potential therapeutic target in PLN R14del cardiomyopathy. Circulation 144, 382\u2013392. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.049844 (2021).","journal-title":"Circulation"},{"key":"19321_CR33","doi-asserted-by":"publisher","unstructured":"Myrthe, Y. C. et al. Identifying predictors for heart failure outcomes in phospholamban p.(Arg14del)-Positive individuals. JACC Heart Fail. 13 https:\/\/doi.org\/10.1016\/j.jchf.2025.102558 (2025).","DOI":"10.1016\/j.jchf.2025.102558"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19321-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19321-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19321-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:48:46Z","timestamp":1760017726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19321-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19321"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19321-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7019046\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35393"}}